MGMT and MLH1 methylation in Helicobacter pylori-infected children and adults

Marisa C Alvarez1, Juliana C Santos, Nathália Maniezzo

  • 1Unidade Integrada de Farmacologia e Gastroenterologia, Universidade São Francisco, Bragança Paulista 12916-900, SP, Brazil.

Abstract

Insights

Helicobacter pylori (H. pylori) infection is linked to MGMT and MLH1 gene methylation in adults, particularly in gastric cancer. This methylation, associated with microsatellite instability, appears to develop over time, not in early infections.

Area of Science:

  • Gastroenterology
  • Oncology
  • Molecular Biology

Background:

  • Helicobacter pylori (H. pylori) infection is a known risk factor for gastric diseases.
  • Gene promoter methylation, specifically of MLH1 and MGMT, plays a role in cancer development.
  • Microsatellite instability (MSI) is a hallmark of certain cancers.

Purpose of the Study:

  • To investigate the association between H. pylori infection and MLH1/MGMT promoter methylation.
  • To explore the relationship between these methylation events and MSI in gastric tissues.
  • To assess methylation patterns across different stages of gastric disease.

Main Methods:

  • Analysis of MLH1 and MGMT promoter methylation using methylation-specific PCR (MSP-PCR).
  • Quantification of MLH1 and MGMT mRNA expression via real-time PCR.
  • MSI analysis using established markers and PCR.
  • Statistical analysis including chi-squared tests and Student's t-tests.

Main Results:

  • No MLH1 or MGMT methylation was observed in children, irrespective of H. pylori status.
  • MGMT promoter methylation was prevalent in adult chronic gastritis (51%) and gastric cancer (66%), associated with H. pylori infection.
  • MLH1 methylation was detected in adult gastric cancer (39%) and linked to increased MSI.
  • Both genes showed higher methylation frequencies in gastric cancer compared to H. pylori-positive chronic gastritis.

Conclusions:

  • MGMT and MLH1 methylation are not present in early H. pylori infections.
  • The development of MLH1 and MGMT methylation may be dependent on the duration of H. pylori infection.
  • These findings highlight the role of epigenetic alterations in H. pylori-associated gastric carcinogenesis.

Related Concept Videos

Gastritis II: Pathophysiology01:26

Gastritis II: Pathophysiology

The pathophysiology of gastritis begins with the colonization of the stomach lining by Helicobacter pylori (H. pylori). This bacterium spreads mainly via the oral-oral route through saliva or shared utensils, and can also be transmitted in overcrowded or unhygienic environments through contaminated water, despite its brief survival outside the body.ColonizationOnce ingested, H. pylori enters the stomach and begins colonization by navigating through the mucus layer lining the stomach wall. It...
Peptic Ulcer01:27

Peptic Ulcer

Peptic ulcers are erosive lesions of the gastric or duodenal lining, most commonly caused by Helicobacter pylori infection. This Gram-negative, helical bacterium has adapted to survive the stomach’s acidic environment by producing urease, which converts urea into ammonia and carbon dioxide. The ammonia neutralizes gastric acid in the bacterium’s immediate environment, allowing colonization of the gastric mucosa. H. pylori attaches to mucus-secreting epithelial cells, penetrates the mucus...
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy01:16

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
Peptic Ulcer Disease II: Pathophysiology01:24

Peptic Ulcer Disease II: Pathophysiology

Peptic ulcer disease develops when protective mechanisms of the gastrointestinal mucosa are overwhelmed by harmful factors, leading to localized erosions in the stomach or proximal duodenum. The main causes are Helicobacter pylori infection and chronic use of nonsteroidal anti-inflammatory drugs (NSAIDs).Helicobacter pylori–Induced InjuryBacterial Adaptation and Colonization:H. pylori is a spiral, Gram-negative bacterium adapted to the acidic stomach. and transmitted through oral-oral or...
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors01:24

Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors

Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI)  tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining. Bicarbonate,...